Scarica l'app Stockscreener
45.64
2.33%
1.04
Dopo l'orario di chiusura:
45.64
Precedente Chiudi:
$44.60
Aprire:
$44.76
Volume 24 ore:
36,679
Relative Volume:
0.92
Capitalizzazione di mercato:
$229.97M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+8.87%
1M Prestazione:
+8.46%
6M Prestazione:
+0.13%
1 anno Prestazione:
+7.59%
Intervallo 1D:
$44.60
$45.66
Intervallo di 1 settimana:
$41.97
$45.66
Portata 52W:
$35.22
$48.76
Spdr Pharmaceuticals Etf Stock (XPH) Company Profile
Nome
Spdr Pharmaceuticals Etf
Settore
Industria
Telefono
-
Indirizzo
-
Confronta XPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XPH
Spdr Pharmaceuticals Etf
|
45.64 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
317.66 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
644.89 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
648.11 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
249.95 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
580.34 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Pharmaceuticals Etf Borsa (XPH) Ultime notizie
PNC Financial Services Group Inc. Sells 917 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Mark Cuban Says Cutting PBM Fees Won't Reduce… - inkl
SPDR Dow Jones REIT ETF (NYSEARCA:RWR) Shares Bought by Cwm LLC - Defense World
BREAKING: Surprise FDA Exit May Boost Biotech ETF XBI - AInvest
Palantir, Nvidia & Tempus AI: The Future of Medicine in 2025 - AInvest
6 Best Health Care Funds and ETFs for 2025 | Investing - Money/ US News
Short bets against S&P 500 healthcare stocks climb in June; MRNA tops list again - MSN
ETFs to Gain on JNJ's Solid Q1 Earnings & Upbeat Outlook - MSN
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' - Benzinga
XPH: Healthcare Dashboard For July (NYSEARCA:XPH) - Seeking Alpha
(XPH) Technical Data - news.stocktradersdaily.com
SA Quant's top healthcare picks amid Q2 earnings season - MSN
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies - Benzinga
The Tariff Tipping Point: Navigating Copper and Pharma Markets in an Era of Trade Rigidity - AInvest
U.S. Tariffs on Copper and Pharmaceuticals: Navigating Sector Shifts and Portfolio Risks - AInvest
Trump's Tariff Tsunami: Navigating Copper Gains and Pharma Headwinds - AInvest
Trading (XPH) With Integrated Risk Controls - news.stocktradersdaily.com
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' - Yahoo Finance
Global pharma stocks down as Trump renews tariff threat - MSN
Wealthcare Advisory Partners LLC Takes $339,000 Position in SPDR SSgA Ultra Short Term Bond ETF (NYSEARCA:ULST) - Defense World
Short bets on S&P 500 Healthcare sector ease in May; MRNA stays most shorted stock - MSN
Kalkine Reports Surge in SPDR S&P 500 Pharma ETF Trading Activity - Kalkine Media
Friday's ETF with Unusual Volume: XPH - Nasdaq
Cetera Investment Advisers Sells 718 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Ameriprise Financial Inc. Decreases Stock Position in SPDR S&P Bank ETF (NYSEARCA:KBE) - Defense World
2,299 Shares in SPDR S&P Aerospace & Defense ETF (NYSEARCA:XAR) Purchased by D. E. Shaw & Co. Inc. - Defense World
Invesco S&P 500 Pure Growth ETF (NYSEARCA:RPG) Stake Boosted by Ameriprise Financial Inc. - Defense World
D. E. Shaw & Co. Inc. Has $363,000 Stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by D. E. Shaw & Co. Inc. - Defense World
D. E. Shaw & Co. Inc. Decreases Holdings in SPDR S&P 600 Small Cap Growth ETF (NYSEARCA:SLYG) - Defense World
Bank of America Corp DE Sells 22,425 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Navigating Geopolitical Storms: How Sector ETFs Can Turn Volatility into Opportunity - AInvest
Trump Sparks New Chapter In Transatlantic Trade War: What The US Buys From Europe - Benzinga
Captrust Financial Advisors Increases Holdings in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
SPDR S&P International Small Cap ETF (NYSEARCA:GWX) Shares Sold by Focus Partners Wealth - Defense World
1,953 Shares in SPDR S&P Semiconductor ETF (NYSEARCA:XSD) Acquired by Focus Partners Wealth - Defense World
US health authorities to set targets for lowering drug prices - Reuters
Here's How Trump Plans To Tackle Drug Prices, And Why It Might Not Work - inkl
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing DistortionCVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
Short bets against S&P 500 healthcare stocks climb in April; MRNA retains top shorted ranking - MSN
A Silent Crash Inside S&P’s Good Day - Forbes
Stock ETFs Surge on China Tariffs Pact; Bonds, Gold Falter - Yahoo Finance
ETFs on the Move Post U.S.-China Trade Deal - Nasdaq
Pharma ETFs in Focus on Trump's Drug Price Overhaul - Yahoo Finance
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks - Benzinga
A Look at Pharma ETFs After Strong Q1 Earnings - Yahoo Finance
Raymond James Financial Inc. Invests $762,000 in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Spdr Pharmaceuticals Etf Azioni (XPH) Dati Finanziari
Non sono disponibili dati finanziari per Spdr Pharmaceuticals Etf (XPH). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.77%
0.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):